Provided by Tiger Fintech (Singapore) Pte. Ltd.

iBio

0.8470
+0.089411.80%
Volume:979.33K
Turnover:817.36K
Market Cap:8.36M
PE:-0.33
High:0.8951
Open:0.7600
Low:0.7585
Close:0.7576
Loading ...

Ibio Inc: Astralbio Eligible for Development & Commercialization Milestone Payments Totaling up to $28 Mln

THOMSON REUTERS
·
02 Jan

iBio expands cardiometabolic, obesity treatment development program

TIPRANKS
·
02 Jan

iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio

GlobeNewswire
·
02 Jan

IBio Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
31 Dec 2024

IBio Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
27 Dec 2024

IBio Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
24 Dec 2024

IBio Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
20 Dec 2024

IBio Inc. Stock Falls Wednesday, Still Outperforms Market

Dow Jones
·
19 Dec 2024

iBio initiated with a Buy at Lucid Capital

TIPRANKS
·
17 Dec 2024

IBio Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
17 Dec 2024

IBio Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
14 Dec 2024

IBio Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
12 Dec 2024

IBio Inc. Stock Outperforms Market Despite Losses On The Day

Dow Jones
·
10 Dec 2024

IBio Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
07 Dec 2024

IBio Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
05 Dec 2024

IBio Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
03 Dec 2024

IBio Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
30 Nov 2024

IBio Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
28 Nov 2024

IBio Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
26 Nov 2024

iBio announces the appointment of Arkowitz, Parada to board of directors

TIPRANKS
·
25 Nov 2024